[Monte Carlo simulation and validation of the multi-leaf collimator of Varian 23EX accelerator].

Nan Fang Yi Ke Da Xue Xue Bao

Department of Radiation Therapy, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China. E-mail:

Published: December 2013

Objective: To simulate the multi-leaf collimator of Varian linear accelerator using Monte Carlo method.

Methods: The multi-leaf collimator model was established using the DYNVMLC module of BEAMnrc and validated by comparison of Monte Carlo simulation and actual measurement results.

Results: The simulation results were well consistent with the actual measurement results with a bias of less than 3%.

Conclusion: The multi-leaf collimator of Varian linear accelerator can be successfully modeled using Monte Carlo method for analysis of the impact of the geometric properties of the multi-leaf collimator on the dose distribution.

Download full-text PDF

Source

Publication Analysis

Top Keywords

multi-leaf collimator
20
collimator varian
12
monte carlo
12
carlo simulation
8
varian linear
8
linear accelerator
8
actual measurement
8
multi-leaf
5
collimator
5
[monte carlo
4

Similar Publications

intra-arc binary collimation (iABC) is a novel treatment technique in which dynamic conformal arcs are periodically interrupted with binary collimation. It has demonstrated its utility through planning studies for the treatment of multiple metastases. However, the binary collimation approach is idealized in the planning system, while the treatment deliveries must adhere to the physical limitations of the mechanical systems involved [e.

View Article and Find Full Text PDF

Quality assurance practices performed before treatment are believed to identify various potential errors. In this study, 2-dimensional (2D) dosimetric results were analyzed by making some intentional mistakes in six different treatment plans. In this way, the detectability of errors was investigated.

View Article and Find Full Text PDF
Article Synopsis
  • Dynamic conformal arc therapy (DCAT) and volumetric modulated arc therapy (VMAT) both provide similar quality for treating brain metastases, but this study focused on how MLC errors during treatment affect dose distribution.
  • Researchers created reference plans and simulated MLC errors using a head phantom, analyzing how these errors influenced dose delivery to the targets and surrounding brain tissue.
  • The findings revealed that while MLC errors affected both techniques' dose distribution similarly, the DCAT technique showed greater resilience, with less variation in target doses compared to VMAT.
View Article and Find Full Text PDF

Purpose: This study presents novel quality assurance (QA) approach for volumetric modulated arc therapy (VMAT) that leverages frame-by-frame electronic portal imaging device (EPID) images integrated into Mobius3D for accurate three-dimensional dose calculations.

Methods: Sequential EPID images for VMAT plans were acquired every 0.4-second by iView system and processed through iterative deconvolution to mitigate blurring from photon scattering.

View Article and Find Full Text PDF

Design and performance of a novel multi-leaf collimator composed of leaves with fixed and movable layers.

Med Phys

January 2025

Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Background: The multi-leaf collimator (MLC) is an advanced device utilized for beam shaping and intensity modulation in radiotherapy. With the framework of the contemporary single-layer MLC featuring a rounded leaf tip, the leaf tip transmission and leakage exert a considerable influence on radiotherapy.

Purpose: To scale down the leakage and transmission from the leaf gap when the opposite leaves are closed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!